tirzepatide surmount Presented today at #ECO2026 ⤵️ The SURMOUNT-MAINTAIN trial found that continuing at the maximum tolerated dose maintained bodyweight reduction and health-related benefits in adults with obesity. Explore the research: https://t.co/RjLxWa5qjV SURMOUNT-2: Tirzepatide Demonstrates Body Weight-Lowering
Description
Book your telehealth consultation today and take the next step toward better health
If you miss a dose, take it as soon as you remember
Side effects of weight loss meds
p=0.006)
Explore what research shows about tirzepatide for lipedema, including dual GIP/GLP-1 effects on pathological adipose tissue, fat cell signaling,...
